Latest News & Updates

Breaking News

  • 1 day ago

  • Simantini Singh Deo

Pioneering Pharma Leader Dr. Tathagata Dutta Shares His Journey Of Innovation, Purpose, And Passion
Breaking News
Sanofi Acquires Vigil Neuroscience To Expand Neurology Portfolio With Potential Alzheimer’s Disease Treatment

Simantini Singh Deo

AstraZeneca Acquires EsoBiotec For Up To $1B To Accelerate In Vivo Cell Therapy Innovation

Simantini Singh Deo

Aligos Therapeutics Appoints Laura Kavanaugh As VP, Head Of Legal To Support Clinical And Corporate Growth

Simantini Singh Deo

Arbor Biotechnologies Strengthens Leadership With The Appointment Of Don Haut, Ph.D., As Chief Business Officer

Simantini Singh Deo

Other trending news you may like to read

C4X Discovery Receives Milestone Payment From Sanofi, Reflecting Project Advancement

C4X Discovery receives €8M milestone from Sanofi for pre-clinical progress on oral IL-17A inhibitor for inflammatory diseases.

Simantini Singh Deo

Article

Bio-Thera And Hikma Win FDA Approval For STARJEMZA®, A Stelara® Biosimilar For Inflammatory Diseases

FDA approves Bio-Thera and Hikma’s STARJEMZA®, a Stelara® biosimilar, for immune-mediated inflammatory diseases.

Vaibhavi M.

Article

AstraZeneca’s Imfinzi Reduces Risk Of Progression And Death In Bladder Cancer, CHMP Backs Approval Based On NIAGARA Trial

CHMP backs AstraZeneca’s Imfinzi combo for resectable muscle-invasive bladder cancer based on strong Phase III NIAGARA trial data.

Vaibhavi M.

Article

Vivoryon Secures U.S. Composition Of Matter Patent For Varoglutamstat, Adds To Intellectual Property Portfolio

Vivoryon secures new U.S. patent for varoglutamstat, bolstering IP around its QPCT/L inhibitor with protection potentially through 2049.

Simantini Singh Deo

Article